JNK-IN-8(CAS: 1410880-22-6)

JNK-IN-8 (CAS: 1410880-22-6) falls under the provisions of the REACH regulation in the European Union, which requires manufacturers and importers to register chemical substances and their mixtures. In the USA, the FDA and EPA may require registration, reporting, and potential restrictions based on safety and environmental impact. It is crucial to consult the latest regulatory databases and guidance for specific requirements.

Alternatives to JNK-IN-8 (CAS: 1410880-22-6) include other JNK inhibitors like SP600125 and OXM03. These compounds can be used as substitutes in different syntheses depending on the specific requirements and available reagents. It is essential to evaluate the structural similarity and functional properties before substituting these inhibitors.

Research on JNK-IN-8 (CAS: 1410880-22-6) is trending towards its application in cellular signaling pathways, particularly in cancer and neurodegenerative diseases. Market trends indicate increasing interest in developing JNK inhibitors for therapeutic purposes. Additionally, studies on its mechanism of action and potential side effects are gaining attention.

Waste containing JNK-IN-8 (CAS: 1410880-22-6) should be collected in designated containers and stored in a secure, well-ventilated area. For disposal, it is advisable to use professional chemical waste disposal services. Proper incineration under controlled conditions is recommended. Always follow local regulations and guidelines for handling and disposing of hazardous chemicals to ensure environmental safety and compliance.